| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309493 | Clinica Chimica Acta | 2018 | 7 Pages |
Abstract
Overall, this study indicates that CYTOR may serve as a prognostic biomarker for cancer patients during the follow-up.
Keywords
LIHCliver hepatocellular carcinomalncRNASTADRFSqRT-PCRNOSDFSCOADTCGAEscalong non-coding RNAstomach adenocarcinomaColon adenocarcinomaThe cancer genome atlasepithelial to mesenchymal transitiondisease-free survivaloverall survivalEMTCompeting endogenous RNArelapse-free survivalCancerlung adenocarcinomaceRNAMeta-analysisLUADNewcastle-Ottawa Quality Assessment Scalehazard ratioquantitative real-time reverse transcription polymerase chain reactionprognosisLung squamous cell carcinomaOesophageal carcinomaLUSC
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jiayu Liang, Xin Wei, Zhihong Liu, Dehong Cao, Yongquan Tang, Zijun Zou, Chuan Zhou, Yiping Lu,